Telemedicine

In a significant move to preserve continuity of care for millions of Americans, federal health and drug enforcement agencies have once again prolonged the flexible telehealth prescribing rules for controlled substances that originated during the public health emergency. This joint action by the

In a landmark decision that promises to reshape the landscape of cancer treatment technology in India, the Central Drugs Standard Control Organization (CDSCO) has brought much-needed clarity to a previously ambiguous regulatory environment by finalizing a comprehensive risk-classification list for

The audacious plan to dismantle and rebuild foundational elements of the American healthcare system was unveiled not from a traditional policy forum, but from the high-powered stage of the J.P. Morgan Healthcare Conference, signaling a seismic shift in how Washington intends to engage with the

Health systems across many low- and middle-income countries are straining under the weight of persistent challenges, including critical workforce shortages, fragmented service delivery, and inadequate data systems that limit access to care and perpetuate inequities in health outcomes. These issues

The biopharmaceutical sector is holding its collective breath as a series of high-stakes regulatory decisions promises to redraw competitive maps and dictate market leadership for years to come. The first quarter is not just another period of clinical trial readouts and earnings reports; it

The modern healthcare landscape is navigating a complex web of rising operational costs, increasing administrative burdens, and the ever-present need for more personalized and accessible patient care. In this demanding environment, a technological shift is providing a powerful answer: